Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

SKB's anti-IL-5 MAb in preclinical testing for asthma

May 17, 1996

NK1/NK2 antagonist MDL-105212: Potential antiasthmatic

May 17, 1996

Takeda claims NK1 ligands for respiratory indications

May 17, 1996

PDE IV inhibitor SB-207499 in phase II

May 17, 1996

Byk Gulden reports PDE IV inhibitors for asthma, dermatoses

May 17, 1996

Pentoxifylline claimed for treating cold symptoms

May 17, 1996

R-844: Novel steroid for asthma

May 10, 1996

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

Arris announces preliminary results for APC-366

May 3, 1996

Rupatadine poised to enter phase II

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...